Form 4: Charles River Laboratories CEO James C. Foster Reports Changes in Beneficial Ownership
SEC Form 4 Filing
James C. Foster, Chairman, President, and CEO of Charles River Laboratories, reports a transaction involving the transfer of shares from a GRAT account to direct holdings.
Summary
- On November 8, 2024, James C. Foster, Chairman, President, and CEO of Charles River Laboratories, reported changes in beneficial ownership of the company's common stock.
- Foster transferred 4,500 shares of common stock directly.
- 3,532 shares were transferred from the 2022 GRAT account to direct holdings on November 11, 2024.
- Following the reported transaction, Foster directly owns 184,783 shares of Charles River Laboratories common stock.
- Foster also has indirect ownership through various trusts and a spousal holding.
Sentiment
Score: 5
Explanation: This is a neutral filing related to standard insider trading reporting requirements. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions and is required by the SEC to ensure transparency in the market.
Stakeholder Impact
- The transaction itself is unlikely to have a significant impact on stakeholders.
- The disclosure provides transparency to shareholders regarding executive stock ownership.
Key Dates
| Date | Description |
|---|---|
| 11/08/2024 | Date of the reported transaction. |
| 11/11/2024 | 3,532 shares were transferred from the 2022 GRAT account to Direct holdings. |
| 11/12/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.